共 42 条
[34]
Nemoto A, 2017, CURR THER RES CLIN E, V84, P42, DOI 10.1016/j.curtheres.2017.04.001
[35]
Pérez-Ruixo JJ, 2011, AAPS ADV PHARM SCI, V1, P311, DOI 10.1007/978-1-4419-7415-0_14
[39]
Pharmacokinetic and pharmacodynamic modelling for renal function dependent urinary glucose excretion effect of ipragliflozin, a selective sodium-glucose cotransporter 2 inhibitor, both in healthy subjects and patients with type 2 diabetes mellitus
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
2019, 85 (08)
:1808-1819